Comparative genomic analysis of genogroup 1 and genogroup 2 rotaviruses circulating in seven US cities, 2014-2016.

NVSN RVA USA alleles neutralization epitopes whole-genome sequencing

Journal

Virus evolution
ISSN: 2057-1577
Titre abrégé: Virus Evol
Pays: England
ID NLM: 101664675

Informations de publication

Date de publication:
Jan 2021
Historique:
entrez: 15 9 2021
pubmed: 16 9 2021
medline: 16 9 2021
Statut: epublish

Résumé

For over a decade, the New Vaccine Surveillance Network (NVSN) has conducted active rotavirus (RVA) strain surveillance in the USA. The evolution of RVA in the post-vaccine introduction era and the possible effects of vaccine pressure on contemporary circulating strains in the USA are still under investigation. Here, we report the whole-gene characterization (eleven ORFs) for 157 RVA strains collected at seven NVSN sites during the 2014 through 2016 seasons. The sequenced strains included 52 G1P[8], 47 G12P[8], 18 G9P[8], 24 G2P[4], 5 G3P[6], as well as 7 vaccine strains, a single mixed strain (G9G12P[8]), and 3 less common strains. The majority of the single and mixed strains possessed a Wa-like backbone with consensus genotype constellation of G1/G3/G9/G12-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1, while the G2P[4], G3P[6], and G2P[8] strains displayed a DS-1-like genetic backbone with consensus constellation of G2/G3-P[4]/P[6]/P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2. Two intergenogroup reassortant G1P[8] strains were detected that appear to be progenies of reassortment events between Wa-like G1P[8] and DS-1-like G2P[4] strains. Two Rotarix

Identifiants

pubmed: 34522389
doi: 10.1093/ve/veab023
pii: veab023
pmc: PMC8432945
doi:

Types de publication

Journal Article

Langues

eng

Pagination

veab023

Subventions

Organisme : NCIRD CDC HHS
ID : U01 IP001049
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001158
Pays : United States

Informations de copyright

Published by Oxford University Press 2021. This work is written by a US Government employee and is in the public domain in the US.

Références

J Virol. 2014 May;88(10):5543-58
pubmed: 24599996
Infect Genet Evol. 2013 Aug;18:315-24
pubmed: 23770141
J Infect Dis. 2005 Sep 1;192 Suppl 1:S146-59
pubmed: 16088798
Glycoconj J. 1996 Feb;13(1):19-26
pubmed: 8785483
J Virol. 2004 Jul;78(14):7795-802
pubmed: 15220453
Future Microbiol. 2011 Sep;6(9):1049-65
pubmed: 21958144
PLoS One. 2015 Nov 05;10(11):e0141739
pubmed: 26540260
J Gen Virol. 2016 Feb;97(2):403-410
pubmed: 26588920
Emerg Infect Dis. 2010 Dec;16(12):1844-52
pubmed: 21122212
J Virol. 2008 Apr;82(7):3204-19
pubmed: 18216098
J Gen Virol. 2005 Dec;86(Pt 12):3397-3408
pubmed: 16298987
Lancet. 2007 Nov 24;370(9601):1757-63
pubmed: 18037080
J Med Virol. 2010 May;82(6):1083-93
pubmed: 20419826
Infect Genet Evol. 2016 Sep;43:338-42
pubmed: 27237948
J Virol. 1994 Jun;68(6):3955-64
pubmed: 7514681
PLoS One. 2017 Jun 22;12(6):e0178855
pubmed: 28640820
Arch Virol. 2015 Jul;160(7):1693-703
pubmed: 25944143
J Gen Virol. 2017 Feb;98(2):134-142
pubmed: 27983480
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Genome Announc. 2017 Nov 22;5(47):
pubmed: 29167260
Lancet Infect Dis. 2008 Oct;8(10):642-9
pubmed: 18922486
J Virol. 2018 Jan 17;92(3):
pubmed: 29142125
Acta Microbiol Immunol Hung. 2012 Sep;59(3):411-21
pubmed: 22982644
Infect Genet Evol. 2015 Mar;30:206-218
pubmed: 25562122
J Gen Virol. 2009 Jun;90(Pt 6):1423-1432
pubmed: 19264638
J Virol. 2014 Apr;88(7):3789-801
pubmed: 24429371
Infect Genet Evol. 2013 Aug;18:132-44
pubmed: 23684631
Nature. 2004 Aug 26;430(7003):1053-8
pubmed: 15329727
Clin Lab Med. 2015 Jun;35(2):363-91
pubmed: 26004648
Infect Genet Evol. 2016 Oct;44:137-144
pubmed: 27370571
Infect Genet Evol. 2018 Jan;57:166-170
pubmed: 29187315
Pediatrics. 2013 Jul;132(1):e25-33
pubmed: 23776114
Lancet Infect Dis. 2014 Sep;14(9):847-56
pubmed: 25082561
Infect Genet Evol. 2014 Dec;28:426-33
pubmed: 25111613
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2106-2108
pubmed: 28183796
J Med Virol. 2010 Apr;82(4):712-9
pubmed: 20166186
Arch Virol. 2011 Aug;156(8):1397-413
pubmed: 21597953
J Gen Virol. 2013 Jan;94(Pt 1):136-142
pubmed: 23052396
Science. 2009 Jun 12;324(5933):1444-7
pubmed: 19520960
J Gen Virol. 1990 Nov;71 ( Pt 11):2615-23
pubmed: 1701477
J Infect Dis. 2011 Jan 15;203(2):188-95
pubmed: 21288818
EMBO J. 2002 Mar 1;21(5):885-97
pubmed: 11867517
Pediatrics. 2009 Aug;124(2):465-71
pubmed: 19581260
Pediatr Infect Dis J. 2009 Nov;28(11):948-53
pubmed: 19859013
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
J Med Virol. 2007 Nov;79(11):1775-82
pubmed: 17854032
Emerg Infect Dis. 2013 Nov;19(11):1843-6
pubmed: 24188273
J Virol. 2006 Feb;80(3):1513-23
pubmed: 16415027
J Med Virol. 2010 May;82(5):878-85
pubmed: 20336736
PLoS Pathog. 2009 Oct;5(10):e1000634
pubmed: 19851457
Infect Genet Evol. 2009 Dec;9(6):1225-31
pubmed: 19631763
Infect Genet Evol. 2014 Jan;21:58-66
pubmed: 24184096
Vaccine. 2012 Apr 27;30 Suppl 1:A122-30
pubmed: 22520121
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
J Virol. 2018 Dec 10;93(1):
pubmed: 30333170
Pediatrics. 2010 Feb;125(2):e438-41
pubmed: 20100758
Pediatrics. 2008 Dec;122(6):1235-43
pubmed: 19047240
J Infect Dis. 2016 Sep 1;214(5):732-8
pubmed: 27302190
MMWR Recomm Rep. 2009 Feb 6;58(RR-2):1-25
pubmed: 19194371
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Immunome Res. 2007 Sep 18;3:8
pubmed: 17877819
Infect Genet Evol. 2014 Dec;28:446-61
pubmed: 25224179
Sci Rep. 2016 Sep 26;6:34209
pubmed: 27666390
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2349-2354
pubmed: 28137864
J Virol. 2009 Jun;83(12):6135-48
pubmed: 19357162
J Virol Methods. 2013 Dec;194(1-2):242-9
pubmed: 24036075
Emerg Infect Dis. 2014 Jun;20(6):1030-3
pubmed: 24856174
Annu Rev Microbiol. 1997;51:225-55
pubmed: 9343350
Virology. 2005 Feb 5;332(1):177-88
pubmed: 15661150
Infect Genet Evol. 2012 Oct;12(7):1355-61
pubmed: 22610044
J Infect Dis. 2012 Aug 1;206(3):377-83
pubmed: 22615314
Comput Biol Chem. 2009 Aug;33(4):344-9
pubmed: 19665933
J Infect Dis. 2021 Apr 02;:
pubmed: 33822119
Pediatrics. 2011 Aug;128(2):e267-75
pubmed: 21768317
JAMA Pediatr. 2018 Oct 1;172(10):958-965
pubmed: 30105384
J Virol. 1997 Nov;71(11):8213-20
pubmed: 9343172
J Virol. 2006 Nov;80(21):10724-33
pubmed: 16928744
Mol Biol Evol. 2015 Aug;32(8):2060-71
pubmed: 25858434
Infect Genet Evol. 2018 Jan;57:46-50
pubmed: 29128517
J Virol. 2012 Sep;86(17):9148-62
pubmed: 22696651
Arch Virol. 2008;153(8):1621-9
pubmed: 18604469
J Gen Virol. 2011 Apr;92(Pt 4):952-60
pubmed: 21228131
J Virol. 2010 Feb;84(4):1764-70
pubmed: 20007281
BMC Microbiol. 2009 Nov 23;9:238
pubmed: 19930627
Infect Genet Evol. 2014 Dec;28:513-23
pubmed: 25301114
J Clin Microbiol. 2012 Mar;50(3):966-76
pubmed: 22189107

Auteurs

Mathew D Esona (MD)

Division of Viral Diseases, Centers for Disease Control and Prevention, Viral Gastroenteritis Branch, Atlanta, GA, USA.

Rashi Gautam (R)

Division of Viral Diseases, Centers for Disease Control and Prevention, Viral Gastroenteritis Branch, Atlanta, GA, USA.

Eric Katz (E)

Cherokee Nation Assurance, Contracting Agency to the Division of Viral Diseases, Centers for Disease Control and Prevention, Arlington, VA, USA.

Jose Jaime (J)

Division of Viral Diseases, Centers for Disease Control and Prevention, Viral Gastroenteritis Branch, Atlanta, GA, USA.

M Leanne Ward (ML)

Division of Viral Diseases, Centers for Disease Control and Prevention, Viral Gastroenteritis Branch, Atlanta, GA, USA.

Mary E Wikswo (ME)

Division of Viral Diseases, Centers for Disease Control and Prevention, Viral Gastroenteritis Branch, Atlanta, GA, USA.

Naga S Betrapally (NS)

Division of Viral Diseases, Centers for Disease Control and Prevention, Viral Gastroenteritis Branch, Atlanta, GA, USA.

Slavica M Rustempasic (SM)

Division of Viral Diseases, Centers for Disease Control and Prevention, Viral Gastroenteritis Branch, Atlanta, GA, USA.

Rangaraj Selvarangan (R)

Kansas City Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.

Christopher J Harrison (CJ)

Kansas City Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.

Julie A Boom (JA)

Texas Children's Hospital, Houston, TX, USA.

Jan Englund (J)

Seattle Children's Hospital, Seattle, WA, USA.

Eileen J Klein (EJ)

Seattle Children's Hospital, Seattle, WA, USA.

Mary Allen Staat (MA)

Division of Infectious Diseases, Department of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Monica M McNeal (MM)

Division of Infectious Diseases, Department of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Natasha Halasa (N)

Vanderbilt University Medical Center, Nashville, TN, USA.

James Chappell (J)

Vanderbilt University Medical Center, Nashville, TN, USA.

Geoffrey A Weinberg (GA)

University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Daniel C Payne (DC)

Division of Viral Diseases, Centers for Disease Control and Prevention, Viral Gastroenteritis Branch, Atlanta, GA, USA.

Umesh D Parashar (UD)

Division of Viral Diseases, Centers for Disease Control and Prevention, Viral Gastroenteritis Branch, Atlanta, GA, USA.

Michael D Bowen (MD)

Division of Viral Diseases, Centers for Disease Control and Prevention, Viral Gastroenteritis Branch, Atlanta, GA, USA.

Classifications MeSH